Advertisement
Screener

ALIGN TECHNOLOGY, INC. (ALGN) Operating Margin

ALIGN TECHNOLOGY, INC. (ALGN) Operating Margin

  • Operating margin · 12 months: Value 13.23%; Formula and calculation Operating income / revenue. Period ending 2026-06-30..

Operating margin

Overview →

Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.

MetricValueFormula and calculation
Operating margin · 12 months13.23%Operating income / revenue. Period ending 2026-06-30.

$547.59M ÷ $4.14B × 100 ≈ 13.23%

Calculation inputs

InputAmount with unitRaw financial data
Operating income547.59M USDOperating Income (Loss)
Revenue4.14B USDRevenue from Contract with Customer, Excluding Assessed Tax
Cost of products and services(m)
Research and development377.00M USDResearch and Development Expense
Selling, general and administration1.79B USDSelling, General and Administrative Expense

Calculated history

Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.

Period endingOperating income (USD)Revenue (USD)Cost of products and services (USD)Research and development (USD)Selling, general and administration (USD)Operating margin
2026-06-30$547.59M$4.14B(m)$377.00M$1.79B13.23%
2026-03-31$556.61M$4.10B(m)$371.37M$1.77B13.59%
2025-12-31$545.75M$4.03B(m)$369.91M$1.76B13.53%
2025-09-30$534.58M$3.98B(m)$381.75M$1.74B13.42%
2025-06-30$600.58M$3.96B(m)$373.75M$1.76B15.15%
2025-03-31$584.59M$3.98B(m)$369.54M$1.76B14.69%
2024-12-31$607.63M$4.00B(m)$364.20M$1.76B15.19%
2024-09-30$635.02M$3.96B(m)$351.48M$1.74B16.03%
2024-06-30$639.07M$3.94B(m)$354.95M$1.71B16.21%
2024-03-31$663.96M$3.92B(m)$351.24M$1.72B16.95%
2023-12-31$643.34M$3.86B(m)$346.83M$1.70B16.66%
2023-09-30$584.45M$3.81B(m)$348.19M$1.71B15.35%
2023-06-30$561.76M$3.74B(m)$336.42M$1.70B15.03%
2023-03-31$578.03M$3.70B(m)$320.90M$1.67B15.60%
2022-12-31$642.60M$3.73B(m)$305.26M$1.67B17.21%
2022-09-30$750.83M$3.86B(m)$294.21M$1.72B19.43%
2022-06-30$868.33M$3.99B(m)$282.83M$1.75B21.76%
2022-03-31$949.04M$4.03B(m)$267.58M$1.75B23.54%
2021-12-31$976.40M$3.95B(m)$250.31M$1.71B24.70%
2021-09-30$968.69M$3.76B(m)$226.73M$1.61B25.79%
2021-06-30$884.60M$3.47B(m)$205.67M$1.49B25.46%
2021-03-31$542.70M$2.82B(m)$188.31M$1.31B19.27%
2020-12-31$387.17M$2.47B(m)$175.31M$1.20B15.66%
2020-09-30$325.14M$2.29B(m)$167.75M(m)14.22%
2020-06-30$275.22M$2.16B(m)$162.90M(m)12.74%
2020-03-31$524.71M$2.41B(m)$161.39M(m)21.78%
2019-12-31$542.49M$2.41B(m)$157.36M(m)22.54%
2019-09-30$511.82M$2.29B(m)$151.84M(m)22.34%
2019-06-30$509.87M$2.19B(m)$144.86M(m)23.29%
2019-03-31$456.07M$2.08B(m)$136.81M(m)21.94%
2018-12-31$466.56M$1.97B(m)$128.90M(m)23.73%
2018-09-30$455.70M$1.85B(m)$119.27M(m)24.58%
2018-06-30$429.25M$1.73B(m)$110.77M(m)24.76%
2018-03-31$390.13M$1.60B(m)$104.35M(m)24.38%
2017-12-31$353.61M$1.47B(m)$97.56M(m)24.00%
2017-09-30$312.38M$1.35B(m)$93.00M(m)23.22%
2017-06-30$275.69M$1.24B(m)$89.21M(m)22.26%
2017-03-31$257.26M$1.15B(m)$83.44M(m)22.34%
2016-12-31$248.92M$1.08B(m)$75.72M(m)23.05%
2016-09-30$239.89M$1.02B(m)$68.00M$459.97M23.59%
2016-06-30$215.85M$945.99M(m)$65.36M$435.01M22.82%
2016-03-31$193.04M$886.12M(m)$62.44M$414.17M21.79%
2015-12-31$188.63M$845.49M(m)$61.24M$390.24M22.31%
2015-09-30$180.79M$813.81M(m)$60.62M(m)22.22%
2015-06-30$194.29M$796.05M(m)$55.70M(m)24.41%
2015-03-31$200.70M$779.09M(m)$53.30M(m)25.76%
2014-12-31$193.58M$761.65M(m)$52.80M(m)25.42%
2014-09-30$195.00M$741.35M(m)$50.49M(m)26.30%
2014-06-30$184.92M$715.98M(m)$48.55M(m)25.83%
2014-03-31$174.09M$687.27M(m)$46.18M(m)25.33%
2013-12-31$94.21M$660.21M(m)$44.08M(m)14.27%
2013-09-30$58.36M$624.75M(m)$44.82M(m)9.34%
2013-06-30$21.40M$596.74M(m)$43.86M(m)3.59%
2013-03-31$19.51M$578.54M(m)$43.63M(m)3.37%
2012-12-31$85.59M$560.04M(m)$42.87M(m)15.28%
2012-09-30$94.95M$546.11M(m)$40.73M(m)17.39%
2012-06-30$116.76M$535.50M(m)$39.70M(m)21.80%
2012-03-31$97.34M$509.96M(m)$38.29M(m)19.09%
2011-12-31$90.36M$479.74M(m)$37.15M(m)18.84%
2011-09-30$78.70M$443.73M(m)$34.48M(m)17.74%
2011-06-30$74.31M$413.78M(m)$32.15M(m)17.96%
2011-03-31$103.06M$401.89M(m)$29.27M(m)25.64%
2010-12-31$102.73M$387.13M(m)$26.00M(m)26.54%
2010-09-30(m)(m)(m)(m)(m)(m)
2010-06-30(m)(m)(m)(m)(m)(m)
2010-03-31(m)(m)(m)(m)(m)(m)
2009-12-31$-34.01M$312.33M(m)$22.25M(m)-10.89%
2009-09-30(m)(m)(m)(m)(m)(m)
2009-06-30(m)(m)(m)(m)(m)(m)
2008-12-31$15.51M$303.98M(m)$26.16M(m)5.10%

(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.

Similar stocks

Stock NameCountryMarket CapPE Ratio
MSA Safety Inc (MSA)United States$7.023B21.47
ZIMMER BIOMET HOLDINGS, INC. (ZBH)United States$17.103B20.66
ESTABLISHMENT LABS HOLDINGS INC. (ESTA)$1.954B-65.76
Cadre Holdings, Inc. (CDRE)United States$1.123B33.88
Enovis CORP (ENOV)United States$1.053B-1.18
Anteris Technologies Global Corp. (AVR)United States$0.746B
STERIS plc (STE)Ireland$20.343B25.49
Sanara MedTech Inc. (SMTI)United States$0.323B-6.81
Inogen Inc (INGN)United States$0.139B-7.00
Conexeu Sciences Inc. (CNXU)United States$0.111B